Newsroom

Sorted by: Latest

-

MindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotypes, Reproduced Across Two Independent Campaigns

AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (Nasdaq: HYFT) today reported preclinical dengue data that support a computational prediction its HYFT® platform generated before any animal was immunized. HYFT® computationally identified a candidate pan-serotype structural target on the dengue virus. The subsequent immunization data support that prediction at the antibody-binding level: animals immunized with immunogens designed on the predicted target generated antibodies that cross-rea...
-

QXO Announces Offering of Senior Notes

GREENWICH, Conn.--(BUSINESS WIRE)--QXO, Inc. (NYSE: QXO) (“QXO” or the “Company”) announced today that its wholly owned subsidiary, QXO Building Products, Inc. (the “Issuer”), intends to offer $1.5 billion in Senior Notes due 2031 (the “2031 Notes”) and $1.5 billion in Senior Notes due 2034 (the “2034 Notes” and, together with the 2031 Notes, the “notes”), subject to market and other conditions. If the issuance of the notes closes prior to the consummation of previously announced acquisition (t...
-

GAMCO Investors UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: GAMCO Investors, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  ...
-

LTC Expands SHOP Platform with $54 Million Acquisition and Welcomes MorningStar Senior Living to SHOP

WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--LTC Properties, Inc. (NYSE: LTC) (“LTC” or the “Company”), a real estate investment trust that invests in seniors housing and health care properties, today announced a $54 million SHOP acquisition and the addition of MorningStar Senior Living, the eleventh SHOP operator and ninth new to LTC since launching SHOP in May 2025. Acquisition Highlights Property: $54 million acquisition of a 104-unit assisted living and memory care community in Phoenix, Arizo...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share FIRST TRUST BLOOMBERG GLOBAL SEMICONDUCTOR SUPPLY CHAIN UCITS ETF 01.06.2026 CHPS.LN IE000KXTLDE2 725,002.00 USD 36,564,091.22 50.433  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Global Aerospace & Defence UCITS ETF 01.06.2026 MISL.LN IE000NVDQXE1 4,075,002.00 USD 140,637,784.60 34.512  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - September 01.06.2026 QSEP.LN IE000FQ808R5 450,002.00 USD 11,051,942.66 24.560  ...
-

Francesco Martucci Debuts at No. 5 on 50 Top Pizza USA 2026

MIAMI--(BUSINESS WIRE)--Francesco Martucci Miami just debuted at no. 1 in Miami and at no. 5 in America on the 50 Top Pizza USA 2026 rankings in its first year....
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - May 01.06.2026 GMAY.LN IE000P0FL8E3 1,050,002.00 USD 42,089,071.75 40.085  ...
-

Axium Capital Pte. Ltd.:綜研化学株式会社の取締役および監査役の選任議案への反対推奨に関するお知らせ

シンガポール--(BUSINESS WIRE)--(ビジネスワイヤ) -- Axium Capital Pte. Ltd. (以下「Axium Capital」または「当社」)とその運用ファンドは綜研化学株式会社(証券コード:4972、以下「綜研化学」または「同社」)の株式を議決権ベースで約16%保有している大株主です。 Axium Capitalはスチュワードシップ・コードに基づく責任ある機関投資家として、投資先企業との継続的な対話を通じた企業価値向上および株主共同利益の実現を投資活動の根幹に置いています。 1.本プレスリリースの公表に至った背景および経緯 綜研化学の冨田社長および滝澤IR・財務担当取締役とは、今年1月に複数の方々が同席する形で面談させていただきました。その場では、足元の市場環境認識、同社の強みと課題、企業価値向上に向けた戦略等について意見交換を行い、一定の情報共有はなされました。 その後、当社は綜研化学に対し、株主総会で選任されている各取締役および監査役の経営陣・役員としての適任性を判断するため、各取締役・監査役が同社を取り巻く状況や経営課題等について、どのような...